Open House Biologika Rabattverträge 2026 - 34 Imiglucerase
openRead the notice at vergabe-de ↗
Value
unstated
Published
4 Nov 2026
Deadline
—
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600DE501
Description
Die beteiligten Krankenkassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Imiglucerase zu schließen.
Key facts
- Reference
- OH-Biologika-2026-34
- Procedure
- open
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- 76e83f29-1a03-4078-915d-cc2a4d358ce4
- OCID
- ocds-mnwr74-bd79effd-8410-4df8-9a74-ed0b90d6cf9a
- First seen
- 7 Nov 2026
- Last updated
- 7 Nov 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/99b1ee18-25c0-4403-a0df-3d669c3f9d04The source notice is authoritative — verify deadlines and documents there before bidding.